Dr. Matthew Campbell Trinity College Dublin, Ireland

Dr Matthew Campbell graduated from University College Dublin (UCD) in 2006 with a PhD in Biochemistry followed by Post-doctoral research with Prof Pete Humphries in Trinity College Dublin (TCD) in Human Molecular Genetics (2006-2012). He has published extensively on the use of novel technologies to enhance drug delivery to the... read morebrain. Additionally, he has published numerous articles focused on understanding the molecular pathology of diseases such as age-related macular degeneration (AMD), Alzheimer's disease, Schizophrenia, traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE). He leads the Neurovascular Genetics Research group based in the Smurfit Institute of Genetics at TCD where he is also a lecturer. In 2013, he was awarded Science Foundation Ireland's (SFI) most prestigious prize for young researchers, the President of Ireland Young Researcher Award (PIYRA) in relation to his BBB based research. In the same year, he was awarded the Genentech/ARVO fellowship for his ophthalmology focused work related to AMD. This work has led to numerous papers including Nature Medicine (2012, 2014) and Science Translational Medicine (2014) describing the therapeutic potential for a molecule termed Interkeukin-18 (IL-18) and its use in treating patients with AMD. He is co-founder of 2 companies, established to commercialize research outputs from his group.